Arbutus Biopharma Corp. Files 8-K
Ticker: ABUS · Form: 8-K · Filed: Sep 10, 2025 · CIK: 1447028
| Field | Detail |
|---|---|
| Company | Arbutus Biopharma Corp (ABUS) |
| Form Type | 8-K |
| Filed Date | Sep 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, address-change
Related Tickers: ABUS
TL;DR
Arbutus Biopharma (ABUS) updated its address in an 8-K filing.
AI Summary
Arbutus Biopharma Corp. filed an 8-K on September 10, 2025, reporting on other events and financial statements. The filing indicates a change in the company's principal executive offices to 701 Veterans Circle, Warminster, Pennsylvania, 18974. The company was formerly known as Tekmira Pharmaceuticals Corp.
Why It Matters
This filing provides an update on the company's operational address and confirms its corporate identity, which is important for investors tracking its official communications and location.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain information that inherently increases risk.
Key Players & Entities
- Arbutus Biopharma Corp. (company) — Registrant
- Tekmira Pharmaceuticals Corp. (company) — Former company name
- 701 Veterans Circle, Warminster, Pennsylvania, 18974 (location) — New principal executive offices address
FAQ
What is the new principal executive office address for Arbutus Biopharma Corp.?
The new principal executive office address is 701 Veterans Circle, Warminster, Pennsylvania, 18974.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 9, 2025.
What was Arbutus Biopharma Corp. previously known as?
Arbutus Biopharma Corp. was formerly known as Tekmira Pharmaceuticals Corp.
What is the Standard Industrial Classification (SIC) code for Arbutus Biopharma Corp.?
The SIC code for Arbutus Biopharma Corp. is 2834, which corresponds to Pharmaceutical Preparations.
What is the IRS Employer Identification Number (EIN) for Arbutus Biopharma Corp.?
The IRS Employer Identification Number (EIN) for Arbutus Biopharma Corp. is 98-0597776.
Filing Stats: 467 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-10 09:00:46
Filing Documents
- f8k_091025.htm (8-K) — 20KB
- exh_991.htm (EX-99.1) — 233KB
- sign.jpg (GRAPHIC) — 10KB
- sign1.jpg (GRAPHIC) — 10KB
- 0001171843-25-005815.txt ( ) — 488KB
- abus-20250909.xsd (EX-101.SCH) — 3KB
- abus-20250909_lab.xml (EX-101.LAB) — 33KB
- abus-20250909_pre.xml (EX-101.PRE) — 22KB
- f8k_091025_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On September 9, 2025, the U.S. District Court for the District of New Jersey issued a claim construction ruling in the lawsuit brought by Arbutus Biopharma Corporation and its licensee Genevant Sciences against Pfizer Inc. and BioNTech SE (Pfizer/BioNTech) seeking damages for infringement of U.S. Patent Nos. 9,504,561, 8,492,359, 11,141,378, 11,298,320 and 11,318,098 in the manufacture and sale of Pfizer/BioNTech's COVID-19 mRNA-based vaccines. A copy of the Court's claim construction order and opinion is filed herewith as Exhibit 99.1 and is incorporated by reference herein.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Claim Construction Order and Opinion, dated September 9, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Arbutus Biopharma Corporation Date: September 10, 2025 By: /s/ Tuan Nguyen Name: Tuan Nguyen Title: Chief Financial Officer